Experienced in X-Linked Agammaglobulinemia

Stephen D. Betschel

Toronto, ON, CA 
Experienced in X-Linked Agammaglobulinemia
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Stephen Betschel practices in Toronto, Canada. Mr. Betschel is rated as an Experienced expert by MediFind in the treatment of X-Linked Agammaglobulinemia. His top areas of expertise are Angioedema, Hereditary Angioedema, Hives, and Common Variable Immune Deficiency.

His clinical research consists of co-authoring 67 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of X-Linked Agammaglobulinemia.

Gender
Male

Locations

Toronto, ON, Canada
Other Locations
Division Of Allergy And Clinical Immunology St. Michael's Hospital, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)
An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)
Enrollment Status: Completed
Publish Date: March 30, 2023
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: December 09, 2022
Intervention Type: Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

67 Total Publications

Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE
Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE
Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
Published: October 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Betschel's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile